Financial planning in pharma industry: Tillots Pharma Case Study

Discover how Tillotts Pharma achieves flexible financial plans by implementing CCH Tagetik Finance Transformation Platform.

Part of the Japanese Zeria Group, Tillotts Pharma is a fast-growing international specialty pharma company founded in 1963. Tillotts has more than 300 employees at its headquarters near Basel, Switzerland, and around the world. Its products, including in-licensed products, are marketed in more than 65 countries globally. Tillotts and its affiliates around Europe comprise eight companies with total revenues in 2019 of CHF 176.4 million.

Pharma needs to leverage diverse, highly granular data, with products typically sold in multiple countries in different doses, packaging and so on. Tillotts also sells to affiliates, and eliminations for financial statements are quite specific. So to be gathering Excel files from emails was not only time consuming and limiting, but prone to error and causing delays in financial reporting.

Within the eight companies across Europe forming Tillots Pharma, they use CCH Tagetik Consolidation, CCH Tagetik Lease Accounting for IFRS 16, CCH Tagetik Budgeting and Planning plus project, accrual, headcount, cost-centre and sales reporting.

The CCH Tagetik Analytic Information Hub is the performance engine that will centralize and transform Tillotts’ data for analysis and reporting even more.